STRIDE is a pilot study aiming at determining the effectiveness of a manual therapy protocol and a dynamic jaw opening device on jaw function and trismus symptoms. For more information, see the pamphlet below or click here to navigate to the clinical trail registration page. STRIDE is just getting started, so stay tuned for more information.
ACE is a 5-year study evaluating the benefit from, and implementation of, an Alberta wide clinic-to-community-based cancer and exercise model of care – the Alberta Cancer Exercise (ACE) Program. See the pamphlet below for more information or click here, to check out the ACE website.
TARGET is a randomized controlled trial examining 12-week, 24-week, and one-year outcomes from a combined therapeutic and physical exercise program that aims to bridge head-and-neck cancer survivors from acute care rehabilitation services to community-based exercise programming. See the pamphlet below for more information or click here to navigate to the clinical trial registration page.
DREAM is a randomized controlled trial examining the effects of a 12-week decongestive progressive resistance exercise program with advanced compression on breast cancer related lymphedema. For more information, see the pamphlet below, or click here to navigate to the clinical trial registration page.
TITAN is a multi-centre collaborative study lead by Dr. Ian Paterson. It is a randomized controlled trial examining the effect of a multi-disciplinary assessment and early intervention strategy to prevent short and long-term side effects resulting from cancer and cancer treatments in patients who are undergoing treatment for breast cancer and lymphoma. The Cancer Rehabilitation Clinic is the site for the exercise portion of this comprehensive intervention.